Suchergebnisse - "E9L2885WUL"

PubPharm (17)

1

Discovery of Novel Bruton's Tyrosine Kinase PROTACs with Enhanced Selectivity and Cellular Efficacy

enthalten in: Journal of medicinal chemistry | 2023

von Li, Y. | Lannigan, W. | Davoodi, S. | +7

2

Investigation of Fenebrutinib Metabolism and Bioactivation Using MS3 Methodology in Ion Trap LC/MS

enthalten in: Molecules (Basel, Switzerland) | 2023

von Alsibaee, A. | Aljohar, H. | Attwa, M. | +2

3

Fenebrutinib and BTK inhibition : Unveiling a new target for the treatment of chronic spontaneous urticaria

enthalten in: Allergy | 2023

von Carvallo, A. | Sánchez-Fernández, S. | Morales-Palacios, M.

4

Battling BTK mutants with noncovalent inhibitors that overcome Cys481 and Thr474 mutations in Waldenström macroglobulinemia therapy : structural mechanistic insights on the role of fenebrutinib

enthalten in: Journal of molecular modeling | 2022

von Elamin, G. | Aljoundi, A. | Alahmdi, M. | +2

5

Spontaneous Platelet Aggregation in Blood Is Mediated by FcγRIIA Stimulation of Bruton's Tyrosine Kinase

enthalten in: International journal of molecular sciences | 2021

von Duan, R. | Goldmann, L. | Li, Y. | +3

6

Fenebrutinib in H1 antihistamine-refractory chronic spontaneous urticaria : a randomized phase 2 trial

enthalten in: Nature medicine | 2021

von Metz, M. | Sussman, G. | Gagnon, R. | +13

7

Efficacy, Safety, and Pharmacodynamic Effects of the Bruton's Tyrosine Kinase Inhibitor Fenebrutinib (GDC-0853) in Systemic Lupus Erythematosus : Results of a Phase II, Randomized, Double-Blind, Placebo-Controlled Trial

enthalten in: Arthritis & rheumatology (Hoboken, N.J.) | 2021

von Isenberg, D. | Furie, R. | Jones, N. | +20

CommentIn: Arthritis Rheumatol. 2021 Oct;73(10):1773-1775. - PMID 34042321

8

BTK blockers make headway in multiple sclerosis

enthalten in: Nature biotechnology | 2021

von Dolgin, E.

9

Understanding the Effect of Hydroxypropyl-β-Cyclodextrin on Fenebrutinib Absorption in an Itraconazole-Fenebrutinib Drug-Drug Interaction Study

enthalten in: Clinical pharmacology and therapeutics | 2020

von Durk, M. | Jones, N. | Liu, J. | +8

10

Physiologically-Based Pharmacokinetic Model-Informed Drug Development for Fenebrutinib : Understanding Complex Drug-Drug Interactions

enthalten in: CPT: pharmacometrics & systems pharmacology | 2020

von Chen, Y. | Ma, F. | Jones, N. | +6